Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial

• Hoofdauteurs: Lucy N John (Auteur), Camila Gonzalez-Beiras (Auteur), Marti Vall-Mayans (Auteur), Reman Kolmau (Auteur), Wendy Houinei (Auteur), James Wangi (Auteur), Michael Marks (Auteur), Oriol Mitja (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2022-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Summary: Introduction: Neglected tropical diseases control programmes run separately. For settings with more than one endemic disease, combined mass drug administration (MDA) has potential practical advantages compared with separate programmes but needs confirmation of safety. We assessed the safety...